Abstract:Objective To estimate the bioequivalence and pharmacokinetics of two estradiol and norethisterone acetate-containing tablets in healthy post menopausal female volunteers.Methods A single oral dose of test(domestic) and control(imported) estradiol and norethisterone acetate-containing tablets was given 2 mg estradiol and 1 mg norethisterone to 20 volunteers in an open randomized crossover design.The serum concentration of estradoil,estone and norethisterone was determined by chemiluminescence immunoassay method,radioimmunoassay method and HPLC-MS/MS method,respectively.The pharmacokinetic parameters and relative bioavalibility were calculated to evaluate the bioequivalence of two preparations.Results The principle pharmacokinetic parameters of test and control were as follows:①estradoil,Cmax were(102.92±26.68)and(93.52±18.91)pg·mL-1,tmax were(1.05±0.78)and(2.32±1.54)h,t1/2 were(18.97±11.94)and(26.74±16.83)h,AUC0–t were(1621.53±737.76)and(1620.47±735.12)pg·h·mL-1,AUC0–∞ were(1980.43±821.71)and(2187.88±955.43)pg·h·mL-1,the relative bioavalibility F0–t and F0–∞ were(99.84±17.78)% and(94.41±24.98)%,respectively.②estone,Cmax were(313.72±93.89)and(313.05±103.76)pg·mL-1,tmax were(3.93±1.32)and(4.16±1.21)h,t1/2 were(11.86±3.76)and(12.04±5.10)h,AUC0–t were(4480.56±1751.37)and(4622.88±1726.57)pg·h·mL-1,AUC0–∞ were(4665.80±1765.01) and(4878.20±1855.23)pg·h·mL-1,the relative bioavalibility F0–t and F0–∞ were(97.47±15.18)% and(96.71±15.11)%,respectively.③norethisterone,Cmax were(12.73±6.53)and(12.62±6.32)pg·mL-1,tmax were(1.39±0.69)and(1.15±0.57)h,t1/2 were(7.04±2.66)and(7.98±2.66)h,AUC0–t were(46.92±28.16)and(49.28±31.46)ng·h·mL-1,AUC0–∞ were(52.99±32.96)and(56.81±37.07)ng·h·mL-1,the relative bioavalibility F0–t and F0–∞ were(99.74±16.19)% and(97.15±16.04)%,respectively.The main pharmacokinetic parameters showed no statistically significant difference between two preparations.Conclusion The two preparations of estradiol and norethisterone acetate-containing tablets were bioequivalent.

Bioequivalence of Estradiol and Norethisterone Acetate - Containing Tablets in Healthy Post Menopausal Female Volunteers

Study on bioequivalence of cilostazol table in healthy volunteers

Studies on Bioequivalence of Ramipril Capsule in Healthy Volunteers

Pharmacokinetics and relative bioavailability of domestic vs imported cefpodoxime proxetil tablets in human body

Bioequivalence of Levonorgestrel Tablets in Human

Pharmacokinetic and Bioequivalence Studies of Compound Gestodene Tablet in Chinese Healthy Female Adult Volunteers

Bioequivalence of desogestrel/ethinylestradiol tablets in healthy Chinese Han nationality volunteers

Bioequivalence of amlodipine besylate tablets in Chinese healthy volunteers

Bioequivalence of ornidazole tablets in Chinese healthyvolunteers

Bioequivalence of Two Domestic Praperations of Metformin Hydrochloride Entericcoated Capsules in Chinese Healthy Volunteers

Bioequivalence Evaluation of Two Rabeprazole Enteric Coated Formulations in Healthy Chinese Volunteers

Study on Bioequivalence of Ambroxol Hydrochloride Tablets from Domestic and Import

Bioequivalence of Clarithromycin Dispersed Tablet in Health Volunteers

Bioequivalence of Imported and Domestic Risperidone Film-Coated Tablets in Healthy Volunteers

Study on Bioequivalence of Risperidone Tablets

Relative bioavailability of cefpodoxime proxetil tablets in healthy volunteers

Bioequivalence of Domestic and Imported Betahistine Mesylate Tablets in Healthy Volunteers

Bioequivalence study of fluoxetine capsules in healthy volunteers

Pharmacokinetics, safety and bioequivalence of two formulations of progesterone soft capsule in healthy Chinese postmenopausal females: Impacts of a high-fat meal

Bioequivalence of domestic and imported bisoproloi tablets

Bioequivalence of Domestic and Imported Nizatidine Formulations in Chinese Healthy Volunteers